Coumarin-based drugs: a patent review (2008 – present)

Bibliography

• Murray RDH, Mendez J, Brown RA. The Natural Coumarins. J. Wiley & Sons; New York: 1982
   Google Scholar
• Murray RDH. Progress in the chemistry of organic natural products. In: Herz W, Kirby GW, Steglich W, Tamm C, editors. Coumarins. Volume 58 Springer-Verlag; New York: 1991. p. 84-316
   Google Scholar
• Borges F, Roleira F, Milhazes N, Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem 2005;12:887-916
   PubMed Web of Science ®Google Scholar
• Fylaktakidou KC, Hadjipavlou-Litina D, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with antiinflammatory/antioxidant Activities. Curr Pharm Des 2004;10:3813-33
   PubMed Web of Science ®Google Scholar
• He C, Zhang W, Xu X, inventors, The Second Military Medical University, The Chinese People's Liberation Army, Peop. Rep. China, assignee. Application of coumarin compounds in preparing medicine for inducing directional differentiation of neural stem cell. WO040153; 2008
   Google Scholar
• Zhang SY, Meng L, Gao WY, Advances in biological activities of coumarins. Chin J Chin Mater Med 2005;30:410-14
   Google Scholar
• Kubo H, Nagahori H, Tomigahara Y, inventors, Sumitomo Chemical Co. Ltd Japan, assignee. Coumarin compound and use thereof. WO031706; 2009
   Google Scholar
• Luu-The V, Zhang Y, Poirier D, Labrie F. Characteristics of human types 1, 2 and 3 17beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition. J Steroid Biochem Mol Biol 1995;55:581-7
   PubMed Web of Science ®Google Scholar
• Smith HJ, Nicholls PJ, Simons C, Le Lain R. Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers. Exp Opin Ther Patents 2001;11:789-824
   Web of Science ®Google Scholar
• Le Lain R, Barrell KJ, Saeed GS, Some coumarins and triphenylethene derivatives as inhibitors of human testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD type 3): further studies with tamoxifen on the rat testes microsomal enzyme. J Enzyme Inhib Med Chem 2002;17:93-100
   Web of Science ®Google Scholar
• Borsche W, Lewinsohn M. Constituents of kawa root XIV. Cinnamoylacetic esters. Berichte 1933;66B:1792-801
   Google Scholar
• Sova M, Perdih A, Kotnik M, Flavonoids and cinnamic acid esters as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase: a synthesis, QSAR and modelling study. Bioorg Med Chem 2006;14:7404-18
   Google Scholar
• Kubo H, Nagahori H, Tomigahara Y, inventors, Sumitomo Chemical Co., Ltd., Japan, assignee. Coumarin compound and use thereof. WO031709; 2009
   Google Scholar
• Parmar VS, Raj HG, Prasad AK, Jain SC. inventors, Delhi University, India and Vallabhbhai Patel Chest Institute, assignees. Coumarin compounds for the treatment of cardiovascular diseases and process for preparing the same. WO157020; 2009
   Google Scholar
• Heidelbaugh TM, Cappiello JR, Nguyen P, Gomez DG. inventors, Allergan, Inc. USA, assignee. Coumarin compounds as receptors modulators with therapeutic utility. WO050054; 2011
   Google Scholar
• Hale JJ, Neway W, Mills SG, Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720. Bioorg Med Chem Lett 2004;14:3351-5
   Google Scholar
• Calvet JP, Blagg BSJ, Sundar SV, Magenheimer BS. inventors, University of Kansas, USA, assignees. Novobiocin analogues and treatment of polycystic kidney disease. US0082098; 2011
   Google Scholar
• Yu XM, Shen G, Blagg BSJ. Synthesis of (-)-Noviose from 2,3-O-Isopropylidene-D-erythronolactol. J Org Chem 2004;69:7375-8
   Google Scholar
• Madhavan GR, Balraju V, Mallesham B, Novel coumarin derivatives of heterocyclic compounds as lipid-lowering agents. Bioorg Med Chem Lett 2003;13:2547-51
   PubMed Web of Science ®Google Scholar
• Shen G, Yu XM, Blagg BSJ. Syntheses of photolabile novobiocin analogues. Bioorg Med Chem Lett 2004;14:5903-6
   Google Scholar
• Yu XM, Shen G, Neckers L, Hsp90 inhibitors identified from a library of novobiocin analogues. J Am Chem Soc 2005;127:12778-9
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Hempson SJ, Reif GA, Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol 2006;17:178-87
   PubMed Web of Science ®Google Scholar
• Rao JM, Bhimapaka CR, Pullela VS, inventors, Council of Scientific and Industrial Research New Delhi, India, assignee. Pharmaceutical composition useful as acetylcholinesterase inhibitors. US0009544; 2008
   Google Scholar
• Piazzi L, Rampa A, Bisi A, 3-(4-{[Benzyl(methyl)amino]methyl}phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both Acetylcholinesterase and Acetylcholinesterase-induced beta-Amyloid aggregation: a dual function lead for Alzheimer's disease therapy. J Med Chem 2003;46:2279-82
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88-95
   PubMed Web of Science ®Google Scholar
• Orlow SJ, Komatsu LN. inventors, New York University, USA, assignee. Compounds, compositions and methods for preventing skin darkening. US0190229; 2011
   Google Scholar
• Orlow SJ. The biogenesis of melanosomes. In: The pigmentary system: Physiology and Pathophysiology. Nordlund JJ, Boissy RE, Hearing VJ, editors. Oxford University Press; New York: 1998
   Google Scholar
• Liu G, Xue H, Ma T, inventors, Institute of Materia Medica, Chinese Academy of Medical Sciences, Peop. Rep. China, assignee. Tetriacyclodipyranyl coumarins and the anti-HIV and anti-tuberculosis uses thereof. EP2216335; 2010
   Google Scholar
• Donglei Y, Madoka S, Lan X, Recent progress in the development of coumarin derivatives as potent anti-HIV agents. Med Res Rev 2003;23:322-45
   PubMed Web of Science ®Google Scholar
• Kashman Y, Gustafson KR, Fuller RW, The Calanolides, a Novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, calophyllum lanigerum. J Med Chem 1992;35:2735-43
   PubMed Web of Science ®Google Scholar
• Xue H, Lu X, Zheng P, Highly Suppressing Wild-Type HIV-1 and Y181C Mutant HIV-1 Strains by 10-Chloromethyl-11-demethyl-12-oxo-calanolide A with druggable profile. J Med Chem 2010;53:1397-401
   PubMed Web of Science ®Google Scholar
• Ma T, Liu L, Xue H, Chemical library and structure–activity relationships of 11-Demethyl-12-oxo Calanolide A analogues as Anti-HIV-1 Agents. J Med Chem 2008;51:1432-46
   Google Scholar
• Galinis DL, Fuller RW, McKee TC, Structure-Activity Modifications of the HIV-1 Inhibitors (+)-Calanolide A and (-)-Calanolide B1. J Med Chem 1996;39:4507-10
   Google Scholar
• Flavin MT, Rizzo JD, Khilevich A, Synthesis, chromatographic resolution, and anti-human immunodeficiency virus activity of (±)-Calanolide A and its enantiomers. J Med Chem 1996;39:1303-13
   PubMed Web of Science ®Google Scholar
• Xu ZQ, Barrow WW, Suling WJ, Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis. Bioorg Med Chem 2004;12:1199-207
   PubMed Web of Science ®Google Scholar
• Chen ZW, Zhou P, Ho DD, Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997;4:2705-14
   Google Scholar
• Beckwith J, Dutton R, Boyd D, Berkmen M. inventors, President and Fellows of Harvard College, USA, assignee. Antimicrobial agents that target bacterial vitamin K epoxide reductase. WO045381; 2010
   Google Scholar
• Dutton RJ, Wayman A, Wei JR, Inhibition of bacterial disulfide bond formation by the anticoagulant warfarin. Proc Natl Acad Sci 2010;107:297-301
   PubMed Web of Science ®Google Scholar
• Goodstadt L, Ponting CP. Vitamin K epoxide reductase: homology, active site and catalytic mechanism. Trends Biochem Sci 2004;29:289-92
   PubMed Web of Science ®Google Scholar
• Abdelhafez OM, Amin KM, Batran RZ, Synthesis, anticoagulant and PIVKA-II induced by new 4-hydroxycoumarin derivatives. Bioorg Med Chem 2010;18:3371-8
   PubMed Web of Science ®Google Scholar
• Appendino G, Mercalli E, Fuzzati N, Antimycobacterial Coumarins from the Sardinian Giant Fennel (Ferula communis). J Nat Prod 2004;67:2108-10
   PubMed Web of Science ®Google Scholar
• Monti M, Pinotti M, Appendino G, Characterization of anti-coagulant properties of prenylated coumarin ferulenol. Biochim Biophys Acta 2007;1770:1437-40
   PubMed Web of Science ®Google Scholar
• Ansell J, Bargqvist D. Current options in the prevention of thromboembolic disease. Drugs 2004;64:1-5
   PubMed Web of Science ®Google Scholar
• Kulkarni MV, Kulkarni GM, Lin CH, Sun CM. Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents. Curr Med Chem 2006;13:2795-818
   PubMed Web of Science ®Google Scholar
• Iikura H, Hyoudoh I, Aoki T, inventors, Chugai Seiyaku Kabushiki Kaisha, Japan, assignee. Novel coumarin derivatives having antitumor activity. EP1982982; 2008
   Google Scholar
• Sakasai M, Shibuya Y, Nagasawa A. inventors, Kao Corp. Chuo-ku Tokyo, Japan, assignee. NFAT Signal Inhibitor and Hair growing agent. EP2348025A1; 2011
   Google Scholar
• Hsieh H-P, Chang J-Y, Kuo C-C, Chao Y-S. inventors, National Health Research Institutes, Taiwan, assignee. Coumarin Compounds and their use for treating cancer. US0312317; 2009
   Google Scholar
• Kuo CC, Hsieh HP, Pan WY, BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo. Cancer Res 2004;64:4621-8
   PubMed Web of Science ®Google Scholar
• ter Haar E, Kowalski RJ, Hamel E, Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. Biochemistry 1996;9:243-50
   Google Scholar
• Smith AB, Shaw SJ, Myles DC. inventors, The Trustees of the University of Pennsylvania & Kosan Biosciences, Inc., assignees. Discodermolide analogues and methods of their use. WO006184; 2009
   Google Scholar
• Su G. inventor, Nanjing Zhongrui Pharmaceutical Co., Ltd., Peop. Rep. China, assignee. Coumarin derivatives, preparation processes and used there of. WO036656; 2009
   Google Scholar
• Marquez N, Sancho R, Ballero M, Imperatorin inhibits T-cell proliferation by targeting the transcription factor NFAT. Planta Medica 2004;70:1016-21
   Google Scholar
• Sakasai M, Shibuya Y, Nagasawa A. Kao Corp., Tokyo, Japan, NFAT signal inhibitor and Hair-growing agent. WO2010047103A1 2010
   Google Scholar
• Kawasaki C, Okuyama T, Shibata S, Iitaka Y. Studies on coumarins of a Chinese drug "Qian Hu"; VI. Coumarins of Angelica edulis. Planta Medica 1984;50:492-6
   Google Scholar
• Lee K, Min JH, Lee K, inventors, Korea Research Institute of Bioscience and Biotechnology, assignee. Novel Coumarin-based compounds, preparation method thereof and multidrug resistance inhibitory pharmaceutical compositions containing same as active ingredients. WO064817; 2010
   Google Scholar
• Selkoe DJ. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 1998;8:447-53
   PubMed Web of Science ®Google Scholar
• Brown MS, Ye J, Rawson RB, Goldstein JL. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 2000;18:391-8
   Google Scholar
• Zhu L, Djaballah H, Li Y, Shelton CC. inventors, Sloan-Kettering Institute for Cancer Research, New York, USA, assignee. Coumarin-based compounds. WO075280; 2010
   Google Scholar